These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9665183)

  • 21. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB.
    Greco C; D'Agnano I; Vitelli G; Vona R; Marino M; Mottolese M; Zuppi C; Capoluongo E; Ameglio F
    Int J Immunopathol Pharmacol; 2006; 19(1):67-79. PubMed ID: 16569345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bcl-2 overexpression is associated with resistance to dexamethasone, but not melphalan, in multiple myeloma cells.
    Gazitt Y; Fey V; Thomas C; Alvarez R
    Int J Oncol; 1998 Aug; 13(2):397-405. PubMed ID: 9664139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Old and Young Actors Playing Novel Roles in the Drama of Multiple Myeloma Bone Marrow Microenvironment Dependent Drug Resistance.
    Manni S; Carrino M; Semenzato G; Piazza F
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
    Moschetta M; Basile A; Ferrucci A; Frassanito MA; Rao L; Ria R; Solimando AG; Giuliani N; Boccarelli A; Fumarola F; Coluccia M; Rossini B; Ruggieri S; Nico B; Maiorano E; Ribatti D; Roccaro AM; Vacca A
    Clin Cancer Res; 2013 Aug; 19(16):4371-82. PubMed ID: 23804425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma.
    Harousseau JL; Shaughnessy J; Richardson P
    Hematology Am Soc Hematol Educ Program; 2004; ():237-56. PubMed ID: 15561686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential oncogene-related gene expressions in myeloma cells resistant to prednisone and vincristine.
    Mutlu P; Ural AU; Gündüz U
    Biomed Pharmacother; 2012 Oct; 66(7):506-11. PubMed ID: 22681910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating biosignatures in multiple myeloma and their role in multidrug resistance.
    Krishnan SR; Bebawy M
    Mol Cancer; 2023 Apr; 22(1):79. PubMed ID: 37120508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.
    Issa ME; Takhsha FS; Chirumamilla CS; Perez-Novo C; Vanden Berghe W; Cuendet M
    Clin Epigenetics; 2017; 9():17. PubMed ID: 28203307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma.
    Nojima M; Maruyama R; Yasui H; Suzuki H; Maruyama Y; Tarasawa I; Sasaki Y; Asaoku H; Sakai H; Hayashi T; Mori M; Imai K; Tokino T; Ishida T; Toyota M; Shinomura Y
    Clin Cancer Res; 2009 Jul; 15(13):4356-64. PubMed ID: 19549772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma.
    Vincent T; Molina L; Espert L; Mechti N
    Br J Haematol; 2003 Apr; 121(2):259-69. PubMed ID: 12694247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucocorticoids in multiple myeloma: past, present, and future.
    Burwick N; Sharma S
    Ann Hematol; 2019 Jan; 98(1):19-28. PubMed ID: 30073393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemosensitization of myeloma plasma cells by an antisense-mediated downregulation of Bcl-2 protein.
    van de Donk NW; Kamphuis MM; van Dijk M; Borst HP; Bloem AC; Lokhorst HM
    Leukemia; 2003 Jan; 17(1):211-9. PubMed ID: 12529680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-6-independent expression of glucocorticoid receptor is upregulated by triptolide in multiple myeloma.
    Yang M; Shen JK; Huang J; Du HP; Ma QL; Jin J
    Leuk Lymphoma; 2009 May; 50(5):802-8. PubMed ID: 19330649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mechanisms of drug resistance and sensitivity concerning novel agents for multiple myeloma].
    Tokuhira M
    Rinsho Ketsueki; 2016 May; 57(5):563-74. PubMed ID: 27263780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma.
    Yang WC; Lin SF
    Biomed Res Int; 2015; 2015():341430. PubMed ID: 26649299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug resistance in multiple myeloma.
    Robak P; Drozdz I; Szemraj J; Robak T
    Cancer Treat Rev; 2018 Nov; 70():199-208. PubMed ID: 30245231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.